PLAUR and Familial prostate cancer: In animal models of prostate cancer, pharmacological inhibition of uPAR reduced bone colonization of PC3 cells when the cells were administered directly into the vasculature [17] and lung, liver and lymph node metastases are reduced by anti-uPAR antibody treatments in a subcutaneous rat prostate model [18].